Richard B. Brewer

Filings by Richard B. Brewer span 2 companies, the busiest being Dendreon Corp and Capricor Therapeutics, Inc. We count 16 filings; the first trade dates from 15 January 2009 and the latest from 30 March 2012.

Both buying and selling appear: 1 purchase, against 6 sales worth €2.1M. The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 4 share grants and 5 option exercises. So far in 2012, the count stands at 1 purchase and no sales.

The latest filing, published on 2 April 2012, reports an open-market purchase in Capricor Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.